Clinical Trial Update: Study Evaluating of Calcineurin Inhibitors Versus Sirolimus in Renal Allograft Recipient [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial comparing calcineurin inhibitors with sirolimus in renal allograft recipients was terminated; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Sirolimus (Sirolimus)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Kidney Transplantation | Phase 4 | Status: TERMINATED | Results posted: 2012-09-03